Propel Bio Management »

Corcept Therapeutics Incorporated shares owned by Propel Bio Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.0M 148k 40.74

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Delcath Sys Com New (DCTH)
Corcept Therapeutics Incorporated (CORT)
Abeona Therapeutics Com New (ABEO)
Vor Biopharma Com New (VOR)
Kyverna Therapeutics (KYTX)
Milestone Pharmaceuticals (MIST)
Celldex Therapeutics Com New (CLDX)
Compass Pathways Sponsored Ads (CMPS)
Miragen Therapeutics (VRDN)
Inventiva Sa Ads (IVA)
Sab Biotherapeutics Com New (SABS)
Health Sciences Acq Corp 2 (OBIO)

View all positions for Propel Bio Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Vanguard Portfolio Management
Vanguard Capital Management
Parallel Advisors
State Street Corporation
Geode Capital Management
FMR
First Trust Advisors
Dimensional Fund Advisors
Tang Capital Management
Caption Management
UBS Group

View all funds holding Corcept Therapeutics Incorporated